Clinical trials
Alcoholism clinical trials
Below are recruiting alcoholism clinical trials, each written for real people, not researchers. We’re tracking 561 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07452744Enrolling by invitation
Picroliv for non-alcoholic fatty liver disease
This study tests a plant-based medicine called Picroliv for people with non-alcoholic fatty liver disease (NAFLD). It aims to see if it is safe and can reduce fat in the liver.
Chandigarh, ChandigarhAges 18–60 - NCT05828810Recruiting
Testing antiseptic skin cleaning during hip or knee revision surgery
This study checks whether an antiseptic method for cleaning the skin before surgery is safe and helpful for patients having a repeat (revision) hip or knee replacement. It may help reduce the risk of infection related to surgery.
Barrie, OntarioAges 18 years+ - NCT07330830Recruiting
Genetics and fatty liver disease in Caribbean and Indian Ocean populations
This study looks at how a specific gene (PNPLA3) might affect non-alcoholic fatty liver disease (MASLD) in people from Guadeloupe, French Guiana, and Réunion Island. It aims to understand genetic differences that could explain why some people get the disease.
CayenneAges 18 years+ - NCT06104176Recruiting
Virtual reality therapy for alcohol use disorder
This study tests if virtual reality therapy can help people with alcohol use disorder stay abstinent. You must be sober for at least 15 days to participate.
Créteil, Île-de-France RegionAges 18–80 - NCT07272200Recruiting
Genes and alcohol in liver cancer: a study
This study looks at how your genes and alcohol use together affect the risk of liver cancer. It may help find ways to prevent cancer in people with fatty liver disease or moderate alcohol intake.
Milan, MilanoAges 45–75 - NCT07086508Recruiting
A program to reduce teen drinking
This study is testing a program to help high schoolers drink less alcohol. You and a parent would answer questions together online.
Binghamton, New YorkAges 15–65 - NCT07036198Enrolling by invitation
Alcohol reduction program for UW students
This study is testing a new program to help University of Washington students who drink alcohol to cut back or drink more safely. It looks at your drinking habits and offers support.
Seattle, WashingtonAges 18–24 - NCT07198386RecruitingPhase 2
Study of CS060380 tablets for NASH (fatty liver disease)
This trial tests an experimental pill called CS060380 for people with NASH (a type of fatty liver disease that can cause liver damage). You may qualify if you have a liver biopsy showing NASH with early-to-moderate scarring, or an MRI showing at least 10% liver fat, and your liver enzymes are stable.
Fuzhou, FujianAges 18–70 - NCT05957848RecruitingPhase 2
Guanfacine for teens with cannabis use problems
This Phase 2 study tests whether extended-release guanfacine can reduce cannabis use in adolescents and young adults. It may help by targeting brain pathways that can drive cravings or continued use.
Parkville, VictoriaAges 12–25 - NCT06514300Enrolling by invitation
Study of muscle fat in fatty liver disease
This study looks at how fat in the muscles may affect liver disease in people with fatty liver and related conditions like obesity or diabetes. It aims to better understand the connection between muscle fat and liver health.
BrusselsAges 18–75 - NCT07261722Recruiting
Navy Buddy Program to Reduce Risky Drinking and Sexual Violence
This study tests whether a program that helps Navy buddies support each other can reduce risky drinking and sexual violence. You and a friend who also serves would join together.
Buffalo, New YorkAges 18–24 - NCT06115252Recruiting
Brain scan study for young adults responding to programs
This study uses brain scans and follow-up surveys to understand how young adults respond to programs. It may help if you are a right-handed young adult without a history of brain injury or certain mental health conditions.
Dallas, TexasAges 18–19 - NCT07238998Recruiting
App to help high-risk drinkers reduce alcohol use
This study tests a mobile app that uses motivational interviewing to help high-risk drinkers reduce their alcohol consumption. You may be eligible if you want to cut back on drinking and use an Android phone.
Seoul, SeoulAges 19–59 - NCT06814990Recruiting
Heart and liver study for TIPSS patients
This study uses MRI and echocardiography to check heart function in people with alcohol-related liver cirrhosis who need a TIPSS procedure. It aims to learn more about how the heart works in these patients.
Jena, ThuringiaAges 18–99 - NCT07418047Recruiting
Avatar-guided digital help for young adults with alcohol and suicide risk
This study tests a smartphone app with a virtual guide (avatar) to help young adults who have both alcohol use problems and suicidal thoughts. You would be randomly assigned to the avatar-based program or a standard safety planning app. The goal is to see which works better.
Marlborough, MassachusettsAges 18–29 - NCT06374875RecruitingPhase 4
Does metabolic surgery reduce liver scarring?
This study tests if weight loss surgery can improve liver fibrosis (scarring) in people with obesity and advanced liver disease. It may help those considering surgery to know if their liver health can get better.
Phoenix, ArizonaAges 18–75 - NCT07221188RecruitingPhase 3
Efimosfermin alfa for liver scarring in MASH
This study tests an investigational drug called efimosfermin alfa to see if it is safe and tolerable for people who have liver scarring (F2 or F3 stage) from a condition called MASH. The goal is to find out if the drug can help without causing serious side effects.
Arcadia, CaliforniaAges 18–75 - NCT07221227RecruitingPhase 3
Testing a new drug for MASH with moderate scarring
This trial tests a new medicine called Efimosfermin Alfa for people with MASH (a fatty liver disease) and moderate liver scarring. It aims to see if the medicine can improve the liver condition.
Chandler, ArizonaAges 18–75 - NCT07724275Recruiting
Digital recovery support for Black adults in Detroit
This study tests a digital program to help Black adults in early recovery from alcohol problems stay on track. You'd receive weekly text surveys and complete two in-person visits over 13 weeks.
Detroit, MichiganAges 18 years+ - NCT07527871Enrolling by invitation
Emergency care screening and counseling for substance use prevention
This study tests whether screening patients in the emergency department for substance use, followed by a brief counseling session, can help prevent substance use problems and overdoses. You would be asked about your substance use and receive supportive counseling by phone or video.
Columbus, OhioAges 18 years+ - NCT07428538RecruitingPhase 3
Testing larsucosterol for severe alcohol-related hepatitis
This trial tests a new medicine called larsucosterol to see if it helps people with severe alcohol-related hepatitis (liver inflammation from heavy drinking). If you qualify, the study will monitor your safety and recovery over 90 days.
Birmingham, AlabamaAges 18 years+ - NCT05854836Recruiting
Pre-pregnancy support for incarcerated women with substance use
This study tests a preconception (before pregnancy) support program for incarcerated women who have used substances and could become pregnant. It may help improve health and planning before a future pregnancy.
St Louis, MissouriAges 18–49 - NCT06880705Recruiting
Trans-Led Care Study for alcohol and drug support
This study is testing a program designed by and for transgender adults to help with alcohol or drug use problems. It looks at whether a supportive, community-based approach can improve health and well-being.
Chicago, IllinoisAges 18 years+ - NCT03025074Recruiting
Blood sample bank for liver disease research
This study collects blood samples to build a “biobank” (a stored library of samples) for researchers studying liver diseases like hepatitis, fatty liver disease, and liver cancer. It may help future testing and treatments by allowing scientists to study patterns in people with and without liver conditions.
Buffalo, New YorkAges 7 years+
Hear when a new Alcoholism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alcoholism?
- Yes. Clin2 currently lists 561 recruiting alcoholism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alcoholism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alcoholism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.